WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02268 WUXI XDC

Trading 03-18 15:27:34

56.550

+0.750

+1.34%

High57.350	Low55.800	Vol1.77M
Open56.550	D1 Closing55.800	Amplitude2.78%
Mkt Cap71.14B	Tradable Cap71.14B	Total Shares1.26B
T/O100.20M	T/O Rate0.14%	Tradable Shares1.26B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"WUXI XDC","latestPrice":56.55,"timestamp":1773818807222,"preClose":55.8,"halted":0,"volume":1772520,"delay":0,"changeRate":0.013440860215053764,"floatShares":1258000000,"shares":1258000000,"eps":0.829999,"marketStatus":"Trading","change":0.75,"latestTime":"03-18 15:27:34","open":56.55,"high":57.35,"low":55.8,"amount":100201223,"amplitude":0.027778,"askPrice":56.55,"askSize":2500,"bidPrice":56.45,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":1.118336,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1773821400000},"marketStatusCode":2,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":55.8,"openAndCloseTimeList":[[1773797400000,1773806400000],[1773810000000,1773820800000]],"volumeRatio":0.420588,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268/wiki","defaultTab":"wiki","newsList":[{"id":"2620942534","title":"WuXi XDC Cayman says BioDlink tender offer turns unconditional after 60% share acceptances","url":"https://stock-news.laohu8.com/highlight/detail?id=2620942534","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620942534?lang=en_us&edition=fundamental","pubTime":"2026-03-17 18:34","pubTimestamp":1773743640,"startTime":"0","endTime":"0","summary":"WuXi XDC’s offer to buy the remaining shares of BioDlink reached the acceptance threshold after receiving valid acceptances for 463.67 million shares, representing 60% of BioDlink’s voting rights. The related offer to cancel BioDlink’s outstanding share options also became unconditional, with acceptances covering 6.51 million options, or 85.33% of the total. The offers are scheduled to remain open for acceptance until 31 March 2026. Cash settlement for valid acceptances is expected to be made no later than seven business days after the later of the unconditional date and receipt of completed acceptance documents.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this new","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL10xgwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0JY6N72.USD","LU2039709279.SGD","LU0819121731.USD","LU0348825331.USD","LU0359202008.SGD","LU0516423174.USD","LU1688375341.USD","BK1576","BK1141","LU0326950275.SGD","LU0588546209.SGD","BK1589","LU0043850808.USD","LU1242518857.USD","LU0456827905.SGD","LU0856984785.SGD","LU0516422952.EUR","BK1610","LU0039217434.USD","LU1242518931.SGD","LU0417516738.SGD","LU0708995583.HKD","SG9999014674.SGD","LU0823426308.USD","LU0348735423.USD","LU0307460666.USD","02268","LU0516422440.USD","SG9999002463.SGD","LU0051755006.USD","LU0181495838.USD","LU0140636845.USD","LU0327786744.USD","LU0456846285.SGD","LU2488822045.USD","LU0359201612.USD","LU3063872942.SGD","LU0979878070.USD","LU0516423091.SGD","LU1880383366.USD","LU1720050803.USD","LU0823426480.USD","SG9999002562.SGD","LU0320764599.SGD","LU0417516902.SGD","02269","LU1794554557.SGD","LU0572944931.SGD","LU0052750758.USD","LU0516422366.SGD"],"gpt_icon":0},{"id":"1135631735","title":"BIODLINK-B Shares Surge Over 5% in Afternoon Trading as WUXI XDC Acquisition Deadline Extended","url":"https://stock-news.laohu8.com/highlight/detail?id=1135631735","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135631735?lang=en_us&edition=fundamental","pubTime":"2026-03-17 15:30","pubTimestamp":1773732622,"startTime":"0","endTime":"0","summary":"BIODLINK-B (01875) saw its shares rise more than 5% during afternoon trading. At the time of writing, the stock was up 4.04%, trading at HK$43.8 with a turnover of HK$8.16 million. The movement...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1574","LU2488822045.USD","VXUS","BK4588","SG9999014674.SGD","02268","BK4585","01875","BK1161"],"gpt_icon":0},{"id":"1165555890","title":"CMB International Foresees Accelerated Fundamental Improvement in China's Healthcare Sector, Recommends Buying Innovent Bio, 3SBIO, and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1165555890","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165555890?lang=en_us&edition=fundamental","pubTime":"2026-03-17 15:20","pubTimestamp":1773732029,"startTime":"0","endTime":"0","summary":"According to a research report from CMB International, the MSCI China Healthcare Index has risen 0.6% since the beginning of 2026, outperforming the MSCI China Index by 3.5 percentage points. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","LU2242644610.SGD","SG9999014674.SGD","LU2328871848.SGD","LU2097828474.EUR","LU2488822045.USD","BK1583","LU1969619763.USD","01801","BK1219","LU2097828631.EUR","LU2097828714.EUR","BK1589","02268","HK0000165453.HKD","BK1141","01530","BK1593","LU2097828805.USD","LU0455707207.USD","01167","LU0502904849.HKD","159891","02273","LU2097828557.USD"],"gpt_icon":0},{"id":"1156982969","title":"HK Movers | Biotech Stocks Jump. Wuxi XDC up 7%; Junshi Bio up 6%; Remegen, Genscript Bio, Wuxi Apptec up around 5%; Innocare up over 4%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1156982969","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156982969?lang=en_us&edition=fundamental","pubTime":"2026-03-17 10:41","pubTimestamp":1773715275,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. Wuxi XDC up 7%; Junshi Bio up 6%; Remegen, Genscript Bio, Wuxi Apptec up around 5%; Innocare up over 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","02269","06606","09688","03759","01672","09995","02137","09966","03347","02268","09606","06978"],"gpt_icon":0},{"id":"2619195778","title":"WuXi XDC extends BioDlink cash offer deadline to March 27 after 47% share acceptances","url":"https://stock-news.laohu8.com/highlight/detail?id=2619195778","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619195778?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:33","pubTimestamp":1773397994,"startTime":"0","endTime":"0","summary":"BioDlink is seeking to acquire all shares of WuXi XDC it does not already own and to cancel all outstanding share options. As of 16:00 Hong Kong time on March 13, valid acceptances had been received for 359.63 million shares, representing 47% of WuXi XDC’s issued share capital and voting rights. Valid acceptances had also been received for 6.51 million share options, representing 85% of outstanding options. The offer deadline was extended to March 27 after the acceptance condition, which requires BioDlink to reach at least 60% of voting rights, was not met by the initial closing date. Three shareholders have agreed to tender a combined 104.04 million shares by March 17 following the extension.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL5gR6V3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0348825331.USD","LU1242518857.USD","SG9999002463.SGD","LU0417516738.SGD","LU0572944931.SGD","SG9999014674.SGD","02268","LU2488822045.USD","BK1521","LU0823426308.USD","LU0140636845.USD","LU0348735423.USD","LU0327786744.USD","LU0456827905.SGD","LU0856984785.SGD","LU1242518931.SGD","LU0359201612.USD","LU0979878070.USD","LU1880383366.USD","LU0417516902.SGD","02269","BK1610","LU0456846285.SGD","LU0819121731.USD","LU0823426480.USD","LU1688375341.USD","LU0516422440.USD","LU0516422366.SGD","BK1589","LU0181495838.USD","LU1720050803.USD","LU2039709279.SGD","LU0588546209.SGD","LU0359202008.SGD","LU0516423174.USD","LU0043850808.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU0326950275.SGD","BK1576","LU0516423091.SGD","LU0307460666.USD","LU3063872942.SGD","LU0516422952.EUR","LU0052750758.USD","LU0320764599.SGD","LU1794554557.SGD","SG9999002562.SGD","BK1141"],"gpt_icon":0},{"id":"2616530828","title":"Assessing WuXi XDC Cayman (SEHK:2268) Valuation After New Earendil Labs ADC Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530828","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616530828?lang=en_us&edition=fundamental","pubTime":"2026-03-01 09:24","pubTimestamp":1772328295,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman (SEHK:2268) just expanded its ADC platform reach as Earendil Labs secured an exclusive global license to the WuXiTecan-2 payload-linker technology, structured with upfront, milestone and royalty economics.\nSee our latest analysis for WuXi XDC Cayman.\nThe Earendil Labs agreement, which highlights WuXi XDC Cayman’s ADC and payload platform, comes as the shares trade at HK$63.15, with a 1 day share price return of 8.23%, a 30 day share price return of 2.02%, and a 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/assessing-wuxi-xdc-cayman-sehk2268-valuation-after-new-earen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/assessing-wuxi-xdc-cayman-sehk2268-valuation-after-new-earen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADC","BK4080","BK4231","DCF","SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2614830614","title":"BRIEF-Wuxi XDC Enters Strategic Collaboration With Earendil Labs","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830614","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614830614?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:47","pubTimestamp":1772192842,"startTime":"0","endTime":"0","summary":"BRIEF-Wuxi XDC Enters Strategic Collaboration With Earendil LabsFeb 27  - WuXi XDC Cayman Inc 2268.HK:WUXI XDC ENTERS STRATEGIC COLLABORATION WITH EARENDIL LABS ON WUXITECAN-2 PAYLOAD-LINKER TECHNOLOGY PLATFORMWUXI XDC CAYMAN INC - GRANTS EXCLUSIVE  LICENSE TO EARENDIL LABS FOR WUXITECAN-2 TECHNOLOGYWUXI XDC CAYMAN INC - DEAL VALUE COULD REACH $885 MILLION INCLUDING MILESTONE PAYMENTSWUXI XDC CAYMAN INC - CO ELIGIBLE FOR TIERED ROYALTIES ON ADC SALES UPON COMMERCIALIZATION ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA7CN65J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2614833447","title":"WuXi XDC Partners With Earendil Labs on WuXiTecan-2 ADC Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2614833447","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614833447?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183517,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc. has entered a strategic collaboration with Earendil Labs to accelerate development of next-generation antibody-drug conjugates using WuXi XDC’s proprietary WuXiTecan-2 payload-linker technology. WuXi XDC will grant Earendil Labs an exclusive global license for multiple targets and provide CMC development and manufacturing support, while Earendil Labs will lead further development, regulatory submissions, and commercialization. The deal could be worth up to about $885 million including upfront and milestone payments, plus tiered royalties on net sales.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL77YWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","SG9999002463.SGD","LU0456827905.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU0516423091.SGD","BK1589","LU0819121731.USD","LU0051755006.USD","LU0856984785.SGD","LU0140636845.USD","LU1242518931.SGD","LU0359202008.SGD","LU3063872942.SGD","LU0327786744.USD","LU0708995583.HKD","LU0456846285.SGD","LU1720050803.USD","LU1880383366.USD","BK1521","LU0326950275.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0307460666.USD","LU0043850808.USD","02268","LU0516423174.USD","LU0979878070.USD","LU0348825331.USD","LU0588546209.SGD","02269","LU0320764599.SGD","LU0823426308.USD","BK1141","LU0039217434.USD","LU2039709279.SGD","LU1242518857.USD","BK1610","LU1794554557.SGD","LU0417516738.SGD","LU0181495838.USD","LU0417516902.SGD","SG9999002562.SGD","LU1688375341.USD","LU0516422440.USD","SG9999014674.SGD","LU0823426480.USD","LU0348735423.USD","BK1576","LU0052750758.USD"],"gpt_icon":0},{"id":"2614833760","title":"WuXi XDC Cayman Inc - Deal Value Could Reach $885 Mln Including Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2614833760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614833760?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183496,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA7CN65J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2614833710","title":"WuXi XDC Cayman Inc - Co Eligible for Tiered Royalties on ADC Sales Upon Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2614833710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614833710?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA7CN65J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2614833469","title":"WuXi XDC Enters Strategic Collaboration With Earendil Labs on Wuxitecan-2 Payload-Linker Technology Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2614833469","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614833469?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183496,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nTUA7CN65J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"1156838863","title":"WUXI XDC Shares Surge Nearly 8% in Morning Session, Poised to Benefit from Improving XDC CRDMO Sector Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1156838863","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156838863?lang=en_us&edition=fundamental","pubTime":"2026-02-27 12:04","pubTimestamp":1772165087,"startTime":"0","endTime":"0","summary":"WUXI XDC (02268) saw its shares rise over 8% during the trading session. At the time of writing, the stock was up 7.54%, trading at HK$62.75, with a turnover of HK$301 million. The company had...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"1183656801","title":"WuXi XDC Cayman Inc. and BioDlink International (1875) Issue Pink Form of Option Offer Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1183656801","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183656801?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:02","pubTimestamp":1770850976,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc. (the “Offeror”) and BioDlink International Company Limited (stock code: 1875) have jointly announced a Pink Form of Option Offer Acceptance and Cancellation in connection with a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"1190027443","title":"WuXi XDC Cayman (2268) and BioDlink International (1875) Joint Announcement: Composite Document Despatch and Timetable for Voluntary Cash Offers","url":"https://stock-news.laohu8.com/highlight/detail?id=1190027443","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190027443?lang=en_us&edition=fundamental","pubTime":"2026-02-12 07:02","pubTimestamp":1770850948,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc. (Stock Code: 2268) and BioDlink International Company Limited (Stock Code: 1875) jointly announced the despatch of a composite offer and response document on 12 February 2026....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2610962071","title":"Wuxi XDC Cayman Inc. Sends Out Composite Document for Voluntary Cash Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610962071","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610962071?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:45","pubTimestamp":1770849950,"startTime":"0","endTime":"0","summary":"Wuxi XDC Cayman Inc. and BioDlink International Company Limited have issued a joint update regarding the dispatch of a composite document related to a cash offer by Citigroup Global Markets Asia Limited, acting on behalf of the offeror, for all issued shares of Wuxi XDC Cayman Inc. not already owned or agreed to be acquired by the offeror and its concert parties. The update also covers the cancellation of all outstanding share options. Further announcements will be made as the transaction progresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 11, 2026, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL7Lpz6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4504","LU0648001328.SGD","LU0320765646.SGD","LU0128525689.USD","BK4588","LU0098860793.USD","LU1201861249.SGD","LU1791807156.HKD","LU1244550221.USD","LU1244550577.SGD","LU0106831901.USD","LU0130102774.USD","BK4566","LU1162221912.USD","LU0052756011.USD","IE00BSNM7G36.USD","LU0130517989.USD","LU2236285917.USD","LU1668664300.SGD","LU2360032135.SGD","LU2417539215.USD","LU2488822045.USD","LU0170899867.USD","LU0314106906.USD","SG9999014674.SGD","LU2125154935.USD","LU1244550494.USD","LU0162691827.USD","BK4207","LU0310800965.SGD","02268","BK4585","BK1141","LU2462157665.USD","LU1506573853.SGD","LU2456880835.USD","LU0072461881.USD","LU0980610538.SGD","BK4534","LU1267930227.SGD","LU1366192091.USD","BK4559","LU2125154778.USD"],"gpt_icon":0},{"id":"1173844300","title":"BioDlink International (1875) and WuXi XDC Cayman (2268) Jointly Issue Composite Document on Voluntary Conditional Cash Offers","url":"https://stock-news.laohu8.com/highlight/detail?id=1173844300","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173844300?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:45","pubTimestamp":1770849941,"startTime":"0","endTime":"0","summary":"BioDlink International Company Limited (stock code: 1875) and WuXi XDC Cayman Inc. (stock code: 2268) have jointly released a Composite Offer and Response Document dated 12 February 2026. According...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"1133857400","title":"Goldman Sachs: Mainland Healthcare Sector Returns to Hinge on Data and Earnings Visibility This Year, CDMO Firms Favored","url":"https://stock-news.laohu8.com/highlight/detail?id=1133857400","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133857400?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:17","pubTimestamp":1770617841,"startTime":"0","endTime":"0","summary":"According to a research report from Goldman Sachs, the strong trends observed in the mainland healthcare sector last year are expected to continue into this year. However, investors are increasingly...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD","SG9999014674.SGD","LU2242644610.SGD","02268","LU2488822045.USD","LU2125910500.SGD","BK1583","LU2045819591.USD","HK0000165453.HKD","BK4139","LU1046422090.SGD","02359","BK1191","HK0000320223.HKD","HK0000320264.USD","BK1589","03692","159891","CDMO","HK0000306701.USD","LU0708995583.HKD","BK1576","HK0000306685.HKD","LU0052750758.USD","LU0320764599.SGD","02696","BK1141"],"gpt_icon":0},{"id":"1132125759","title":"BOCOM International Forecasts Continued Stable Growth for Healthcare Sector This Year, Recommends Seeking Undervalued Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1132125759","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132125759?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:16","pubTimestamp":1770282992,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index declined 3.3% this week, underperforming the broader market. Since the fourth quarter of last year, the proportion of mainland capital holding pharmaceutical stocks...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1587","03329","BK1191","BK1593","BK1574","01530","HK0000165453.HKD","09939","159938","02268","02595","BK1147","BK1588","BK1161","BK1583","SG9999014674.SGD","BK1141","00013","LU2488822045.USD"],"gpt_icon":0},{"id":"1156157988","title":"WuXi XDC Cayman Inc. (2268), WuXi Biologics (Cayman) Inc. and BioDlink International Company Limited: Delay in Despatch of Offers Circular","url":"https://stock-news.laohu8.com/highlight/detail?id=1156157988","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156157988?lang=en_us&edition=fundamental","pubTime":"2026-02-04 23:04","pubTimestamp":1770217474,"startTime":"0","endTime":"0","summary":"According to an announcement dated 4 February 2026, WuXi XDC Cayman Inc. (the “Company,” Stock Code: 2268), together with WuXi Biologics (Cayman) Inc. and BioDlink International Company Limited,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2608360387","title":"Wuxi XDC Cayman Inc. verschiebt Versand der Angebotsunterlagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608360387?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:10","pubTimestamp":1770214226,"startTime":"0","endTime":"0","summary":"Wuxi XDC Cayman Inc. hat gemeinsam mit BioDlink International Company Limited ein freiwilliges Barangebot für alle ausstehenden Aktien des Unternehmens unterbreitet, mit Ausnahme der bereits vom Bieter und dessen verbundenen Parteien gehaltenen oder zum Erwerb vereinbarten Aktien. Zudem sollen alle ausstehenden Aktienoptionen annulliert werden. Die Verffentlichung der entsprechenden Angebotsunterlagen verzgert sich gegenüber der ursprünglichen Planung.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi XDC Cayman Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 04, 2026, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL5G2sH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU3063872942.SGD","02268","LU0856984785.SGD","LU2488822045.USD","LU0043850808.USD","02269","LU0572944931.SGD","LU0348825331.USD","LU1880383366.USD","SG9999002562.SGD","LU0417516738.SGD","IE00B0JY6N72.USD","LU1688375341.USD","LU0516423091.SGD","BK1589","LU0327786744.USD","LU0823426480.USD","LU1242518931.SGD","LU0359201612.USD","LU1794554557.SGD","BK1610","LU0819121731.USD","LU0039217434.USD","BK1521","LU0516422440.USD","LU1720050803.USD","BK1141","LU0348735423.USD","LU0181495838.USD","LU0140636845.USD","LU0320764599.SGD","LU0823426308.USD","LU1242518857.USD","LU0588546209.SGD","LU0708995583.HKD","LU0051755006.USD","LU0052750758.USD","LU2039709279.SGD","BK1576","LU0516422952.EUR","LU0979878070.USD","LU0326950275.SGD","SG9999014674.SGD","LU0417516902.SGD","LU0516423174.USD","SG9999002463.SGD","LU0307460666.USD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":-0.0542},{"period":"1month","weight":-0.1455},{"period":"3month","weight":-0.1715},{"period":"6month","weight":-0.2168},{"period":"1year","weight":0.3898},{"period":"ytd","weight":-0.0815}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0263},{"period":"3month","weight":0.0157},{"period":"6month","weight":-0.0255},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0093}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi XDC Cayman Inc is an investment holding company principally engaged in the provision of comprehensive contract research, development and manufacturing organization (CRDMO) services for antibody drug conjugate (ADC) and other bioconjugates. The Company's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The Company provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The Company principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"WUXI XDC","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI XDC(02268) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI XDC,02268,WUXI XDC股票,WUXI XDC股票老虎,WUXI XDC股票老虎国际,WUXI XDC行情,WUXI XDC股票行情,WUXI XDC股价,WUXI XDC股市,WUXI XDC股票价格,WUXI XDC股票交易,WUXI XDC股票购买,WUXI XDC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI XDC(02268),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI XDC(02268) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}